RAPS announces board slate; Cooper, Salditt to serve second terms

L to R: Carol Cooper and Diana Salditt

The RAPS nominating committee has selected the slate of new members set to join the board for the term beginning 1 January 2022, following careful review of all nominations for two open director positions.

Following are the two incoming directors:

• Carol Cooper, MS, RAC, IM(ASCP), RM(AAM), principal, CM Cooper and Associates
• Diana Salditt, FRAPS, independent regulatory advisor, (formerly) senior program director, Medtronic 

Both Cooper and Salditt are current first-term board members in good standing who applied and were selected for a second term.

“These individuals have the knowledge, visibility, depth and breadth of experience, and commitment necessary to serve the organization well into the future. We are very encouraged by these regulatory professionals who are so enthusiastic and eager to serve in such an important leadership capacity,” said Nominating Committee Chair Don Boyer, BSc (Hons), RAC, FRAPS.

In accordance with RAPS bylaws, members may submit additional nominations through written petition, which must specify a qualified candidate’s name and position sought, and must bear the names, contact information and signatures of at least 50 active or life members in good standing. Petitions must be submitted electronically to the RAPS nominating committee via nominations@raps.org by 12 July 2021. If no nomination petitions are received, the slate of incoming board members will be confirmed on 13 July 2021.